BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1993559)

  • 1. The mast cell in fibrosis.
    Rothe MJ; Kerdel FA
    Int J Dermatol; 1991 Jan; 30(1):13-6. PubMed ID: 1993559
    [No Abstract]   [Full Text] [Related]  

  • 2. Mast cells and fibrosis. The relevance to scleroderma.
    Claman HN
    Rheum Dis Clin North Am; 1990 Feb; 16(1):141-51. PubMed ID: 2406804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrotic and sclerotic manifestations of chronic graft-versus-host disease.
    Kitko CL; White ES; Baird K
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S46-52. PubMed ID: 22226112
    [No Abstract]   [Full Text] [Related]  

  • 4. Scleroderma-like disorders.
    Foti R; Leonardi R; Rondinone R; Di Gangi M; Leonetti C; Canova M; Doria A
    Autoimmun Rev; 2008 Feb; 7(4):331-9. PubMed ID: 18295739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized cutaneous fibrosing disorders.
    Yaqub A; Chung L; Rieger KE; Fiorentino DF
    Rheum Dis Clin North Am; 2013 May; 39(2):347-64. PubMed ID: 23597968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On scleroderma. Mast cells, endothelial cells, and fibroblasts.
    Claman HN
    JAMA; 1989 Sep; 262(9):1206-9. PubMed ID: 2668581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of the fibrosis in scleroderma skin.
    Fleischmajer R; Perlish JS
    Prog Clin Biol Res; 1984; 154():381-404. PubMed ID: 6382305
    [No Abstract]   [Full Text] [Related]  

  • 8. Mast cells in murine graft-versus-host disease: a model of immunologically induced fibrosis.
    Choi KL; Claman HN
    Immunol Ser; 1989; 46():641-51. PubMed ID: 2488873
    [No Abstract]   [Full Text] [Related]  

  • 9. Mast cell numbers in diffuse scleroderma.
    Nishioka K; Kobayashi Y; Katayama I; Takijiri C
    Arch Dermatol; 1987 Feb; 123(2):205-8. PubMed ID: 3813593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical methods for disease monitoring in dermatology.
    Seidenari S
    Curr Probl Dermatol; 1998; 26():108-19. PubMed ID: 9597321
    [No Abstract]   [Full Text] [Related]  

  • 11. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
    Clements PJ; Roth MD; Elashoff R; Tashkin DP; Goldin J; Silver RM; Sterz M; Seibold JR; Schraufnagel D; Simms RW; Bolster M; Wise RA; Steen V; Mayes MD; Connelly K; Metersky M; Furst DE;
    Ann Rheum Dis; 2007 Dec; 66(12):1641-7. PubMed ID: 17485423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation.
    Akimoto S; Ishikawa O; Igarashi Y; Kurosawa M; Miyachi Y
    Br J Dermatol; 1998 Mar; 138(3):399-406. PubMed ID: 9580789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of transforming growth factor type beta3 (TGF-beta3) and mast cells in the pathogenesis of scleroderma.
    Ozbilgin MK; Inan S
    Clin Rheumatol; 2003 Sep; 22(3):189-95. PubMed ID: 14505209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More about mast cells and fibrosis in porphyria cutanea tarda.
    Claman HN
    Hepatology; 1990 May; 11(5):895-6. PubMed ID: 2347561
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic graft-vs.-host disease: changes in natural suppressor cells and mast cells.
    Claman HN; Holda JH; Maier T; Choi KL
    Isr J Med Sci; 1988 Jul; 24(7):367-9, 371. PubMed ID: 2969877
    [No Abstract]   [Full Text] [Related]  

  • 16. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.
    Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells and their degranulation in the Tsk mouse model of scleroderma.
    Walker M; Harley R; Maize J; DeLustro F; LeRoy EC
    Proc Soc Exp Biol Med; 1985 Nov; 180(2):323-8. PubMed ID: 4048170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The fibrotic diseases of the skin].
    Kähäri VM; Reitamo S; Granlund H; Uitto J
    Duodecim; 1991; 107(12):957-70. PubMed ID: 1364453
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microcirculation and the nature of morphological changes in the gastric and duodenal mucosa in children with scleroderma].
    Vlasova TM; Sokolovskiĭ GA; Chumakov AM; Daurova NV; Uvarova NN
    Pediatriia; 1983 Nov; (11):48-50. PubMed ID: 6669435
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic and localized scleroderma.
    Chung L; Lin J; Furst DE; Fiorentino D
    Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.